TherapeuticsMD Stock News

TherapeuticsMD Inc (NASDAQ: TXMD ) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ: GDRX ) for $150 million. VitaCare is a consumer-focused digital healthcare platform. TherapeuticsMD will also receive an additional $7 million in cash consideration contingent upon vitaCare''s financial … Full story available on Benzinga.com

Gainers Houston American Energy Corp. (NYSE: HUSA ) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc. (NASDAQ: IMPP ) shares jumped 103.8% to $6.89 as crude oil surged to new highs. Bed Bath & Beyond Inc. (NASDAQ: BBBY ) gained 54.7% to $25.03 after Ryan Cohen purchased a 9.8% stake in the company. TherapeuticsMD, Inc. (NASDAQ: TXMD ) surged 45% to $00.3057 after the company announced it would sell its vitaCare business to GoodRx for $150 million. OceanPal Inc. (NASDAQ: OP ) rose 42.4% to $0.8897 after jumping over 14% on Friday. Indonesia Energy Corporation Limited (NASDAQ: INDO ) shares gained 38.1% to $56.30 amid continued momentum and an increase in the price of oil. ION Geophysical Corporation (NYSE: IO ) climbed 37.5% to $1.10 after jumping around 49% on Friday. Nine Energy Service, Inc. (NYSE: NINE ) rose 33.9% to $2.4097 after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as crude surged to new highs.

NEW YORK , March 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INDO, TXMD, CNR, VET, and USWS. … Full story available on Benzinga.com

TherapeuticsMD (TXMD) will divest its vitaCare prescription services unit to GoodRx (GDRX) for $150M.

Here's what you need to know about trading penny stocks on March 7th The post Trading Penny Stocks? Top Stock Market News for March 7th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Inf

Major players in the gynecology drugs market are Hoffmann-La Roche Ltd. , Pfizer Inc. , Merck & Co. Inc. , Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc. , Lupin Pharmaceuticals Inc. and Ferring Holding SA. Major players in the gynecology drugs market are Hoffmann-La Roche Ltd. , Pfizer Inc. , Merck & Co. Inc. , Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc. , Lupin Pharmaceuticals Inc. and Ferring Holding SA.

TherapeuticsMD, Inc. (NASDAQ:TXMD) with the stream of -1.86% also noticed, India Vipshop Holdings Limited (NYSE:VIPS) encountered a rapid change of 1.42% in the last hour of Wednesday’s trading session. TherapeuticsMD, … The post Hooky Stock: TherapeuticsMD, Inc. (NASDAQ:TXMD), Vipshop Holdings Limited (NYSE:VIPS) appeared first on Stocks Equity .

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its fourth quarter 2021 financial results on Thursday, March 10, 2022, before the opening of the U.S. financial markets. Executive management will host a conference call and webcast to discuss the results and provide a business update as follows: Date: Thursday, March 10, 2022 Time: 8:30 a.m. ET Telephone Access

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its fou

TherapeuticsMD Inc. (NASDAQ:TXMD) at last check was buoying at $0.22 on Friday, February 25, with a rise of 7.34% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.20 and 5Y monthly beta was reading 1.75 with its price kept floating in … TherapeuticsMD Inc. (TXMD) Recovers 21.89% From Low: Are We There Yet? Read More »

TherapeuticsMD Inc. (NASDAQ:TXMD) price on Friday, February 11, rose 1.20% below its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.26. A look at the stock’s price movement, the level at last check in today’s session was $0.26, moving within a range at $0.2585 and $0.2789. The beta value … TherapeuticsMD Inc. (NASDAQ:TXMD) Stock Could Be Worth Considering Read More »

TherapeuticsMD Inc. (NASDAQ:TXMD) price is hovering lower on Tuesday, February 08, dropping -2.58% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

In the last trading session, 4.48 million TherapeuticsMD Inc. (NASDAQ:TXMD) shares changed hands as the company’s beta touched 1.75. With the company’s per share price at $0.27 changed hands at $0.0 or -0.81% during last session, the market valuation stood at $109.64M. TXMD’s last price was a discount, traded about -918.52% off its 52-week high … TherapeuticsMD Inc. (NASDAQ: TXMD): The Stock For Success Over The Next Few Months Read More »

Looking for penny stocks to buy under $1? Check these three out for your watchlist The post 3 Penny Stocks To Watch Under $1 That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, New

TherapeuticsMD Inc (NASDAQ: TXMD) is trading sharply higher after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due